Metal Oxide Nanocatalysts for the Electrochemical Detection of Propofol

Overview

Journal Micromachines (Basel)

Publisher MDPI

Date 2025 Mar 6

PMID 40047559

Authors

David C Ferrier

Janice Kiely

Richard Luxton

Affiliations

Soon will be listed here.

Abstract

Propofol is one of the most widely used intravenous drugs for anaesthesia and sedation and is one of the most commonly used drugs in intensive care units for the sedation of mechanically ventilated patients. The correct dosage of propofol is of high importance, but there is currently a lack of suitable point-of-care techniques for determining blood propofol concentrations. Here, we present a cytochrome P450 2B6/carbon nanotube/graphene oxide/metal oxide nanocomposite sensor for discrete measurement of propofol concentration. Propofol is converted into a quinol/quinone redox couple by the enzyme and the nanocomposite enables sensitive and rapid detection. The metal oxide nanoparticles are synthesised via green synthesis and a variety of metal oxides and mixed metal oxides are investigated to determine the optimal nanocatalyst. Converting propofol into the redox couple allows for the measurement to take place over different potential ranges, enabling interference from common sources such as paracetamol and uric acid to be avoided. It was found that nanocomposites containing copper titanium oxide nanoparticles offered the best overall performance and electrodes functionalised with such nanocomposites demonstrated a limit of detection in bovine serum of 0.5 µg/mL and demonstrated a linear response over the therapeutic range of propofol with a sensitivity of 4.58 nA/μg/mL/mm.

References

Meng Q, Irwin W, Fesser J, Massey K . Interference of ascorbic acid with chemical analytes. Ann Clin Biochem. 2005; 42(Pt 6):475-7. DOI: 10.1258/000456305774538274. View

Brahim S, Narinesingh D, Guiseppi-Elie A . Bio-smart hydrogels: co-joined molecular recognition and signal transduction in biosensor fabrication and drug delivery. Biosens Bioelectron. 2002; 17(11-12):973-81. DOI: 10.1016/s0956-5663(02)00089-1. View

Barr J, Egan T, Sandoval N, Zomorodi K, Cohane C, Gambus P . Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology. 2001; 95(2):324-33. DOI: 10.1097/00000542-200108000-00011. View

Yoon Y, Truong P, Lee D, Ko S . Metal-Oxide Nanomaterials Synthesis and Applications in Flexible and Wearable Sensors. ACS Nanosci Au. 2023; 2(2):64-92. PMC: 10114907. DOI: 10.1021/acsnanoscienceau.1c00029. View

Sramkova I, Amorim C, Sklenarova H, Montenegro M, Horstkotte B, Araujo A . Fully automated analytical procedure for propofol determination by sequential injection technique with spectrophotometric and fluorimetric detections. Talanta. 2013; 118:104-10. DOI: 10.1016/j.talanta.2013.09.059. View

Jackson D, Proudfoot C, Cann K, Walsh T . The incidence of sub-optimal sedation in the ICU: a systematic review. Crit Care. 2009; 13(6):R204. PMC: 2811948. DOI: 10.1186/cc8212. View

Singh J, Dutta T, Kim K, Rawat M, Samddar P, Kumar P . 'Green' synthesis of metals and their oxide nanoparticles: applications for environmental remediation. J Nanobiotechnology. 2018; 16(1):84. PMC: 6206834. DOI: 10.1186/s12951-018-0408-4. View

Hanks F, McKenzie C . Paracetamol in intensive care - intravenous, oral or not at all?. Anaesthesia. 2016; 71(10):1136-40. DOI: 10.1111/anae.13517. View

Chen Y, Liu B, Chen Z, Zuo X . Innovative Electrochemical Sensor Using TiO Nanomaterials to Detect Phosphopeptides. Anal Chem. 2021; 93(30):10635-10643. DOI: 10.1021/acs.analchem.1c01973. View

10.

Diao J, Wang T, Li L . Graphene quantum dots as nanoprobes for fluorescent detection of propofol in emulsions. R Soc Open Sci. 2019; 6(1):181753. PMC: 6366175. DOI: 10.1098/rsos.181753. View

11.

Bosch M, Sanchez A, Sanchez Rojas F, Bosch Ojeda C . Determination of paracetamol: historical evolution. J Pharm Biomed Anal. 2006; 42(3):291-321. DOI: 10.1016/j.jpba.2006.04.007. View

12.

Nies R, Muller C, Pfister R, Binder P, Nosseir N, Nettersheim F . Monitoring of sedation depth in intensive care unit by therapeutic drug monitoring? A prospective observation study of medical intensive care patients. J Intensive Care. 2018; 6:62. PMC: 6137863. DOI: 10.1186/s40560-018-0331-7. View

13.

Barr J, Fraser G, Puntillo K, Wesley Ely E, Gelinas C, Dasta J . Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2012; 41(1):263-306. DOI: 10.1097/CCM.0b013e3182783b72. View

14.

Muthuchamy N, Gopalan A, Lee K . Highly selective non-enzymatic electrochemical sensor based on a titanium dioxide nanowire-poly(3-aminophenyl boronic acid)-gold nanoparticle ternary nanocomposite. RSC Adv. 2022; 8(4):2138-2147. PMC: 9077267. DOI: 10.1039/c7ra09097h. View

15.

Hughes C, McGrane S, Pandharipande P . Sedation in the intensive care setting. Clin Pharmacol. 2012; 4:53-63. PMC: 3508653. DOI: 10.2147/CPAA.S26582. View

16.

Morris M, Levy G . Renal clearance and serum protein binding of acetaminophen and its major conjugates in humans. J Pharm Sci. 1984; 73(8):1038-41. DOI: 10.1002/jps.2600730806. View

17.

Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V . Regulation of uric acid metabolism and excretion. Int J Cardiol. 2015; 213:8-14. DOI: 10.1016/j.ijcard.2015.08.109. View

18.

Devlin J, Skrobik Y, Gelinas C, Needham D, Slooter A, Pandharipande P . Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018; 46(9):e825-e873. DOI: 10.1097/CCM.0000000000003299. View

19.

Regenthal R, Krueger M, Koeppel C, Preiss R . Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs. J Clin Monit Comput. 2003; 15(7-8):529-44. DOI: 10.1023/a:1009935116877. View

20.

Suzuki S, Eastwood G, Bailey M, Gattas D, Kruger P, Saxena M . Paracetamol therapy and outcome of critically ill patients: a multicenter retrospective observational study. Crit Care. 2015; 19:162. PMC: 4411740. DOI: 10.1186/s13054-015-0865-1. View